LongeVC was in full force at the Sheba Medical Center Longevity Conference. Three of our co-founders, Sergey Jakimov, Garri Zmudze, and Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs), took to the stage to share the latest in #longevity, from education to #AI.

Don’t miss our co-founder and managing partner Sergey Jakimov at infosharepl! He’ll speak on Central and Eastern Europe’s largest tech stage about #biotech, #investing, and #longevity. Learn more and register on the Infoshare website ⬇️ infoshare.pl/conference/

How can we build a robust #longevity ecosystem? More collaboration. Read our managing partner Sergey Jakimov’s op-ed in Longevity Technology for more on defeating industry “lemons,” supporting early-stage research, and the power of early success stories. Link ⬇️ longevity.technology/news/collabora…

Biotech is a global pursuit–investors must consider the role of developing countries. Our founding partner Sergey Jakimov spoke with @willowshahnev of Labiotech.eu about the opportunities and challenges of growing #biotech worldwide. Read it here ⬇️ labiotech.eu/in-depth/biote…

Making longevity credible in pharma one year at a time 😊 This year will be epic! longevity.technology/news/ardd-2023…

Great seeing LongeVC recognition from one of the biggest startup community platforms in the Baltic region. Take a look to find out more about our work in the biotech and longevity arena around the world! Thank you for sharing labsoflatvia.com! labsoflatvia.com/en/news/invest…

Is living longer really possible? The answer is a resounding yes, but healthspan is at the heart of the field. #Longevity is a groundbreaking field encompassing #diagnostics, #prevention, #infrastructure & more. Learn more about our mission to defy aging and embrace longevity ⬇️

While biotech funding may be down, we believe the future of the industry remains bright. Our founding partners Sergey Jakimov and Garri Zmudze spoke with @willowshahnev of Labiotech.eu about the current state of biotech investing. Check it out ⬇️ labiotech.eu/in-depth/ventu…

Will hype cycles in #longevity generate breakthroughs? Emerging technology will improve our health, but the industry should avoid adopting tech for tech’s sake. Read more from our co-founder and managing partner in Longevity Technology here ⬇️ longevity.technology/news/longevity…

#Decentralization for clinical research Open research databases, cryptocurrency donation streams, and blockchain-based voting will fuel a new wave of discovery in clinical trials. Read more from our co-founder Garri Zmudze in Clinical Leader here ⬇️ clinicalleader.com/doc/decentrali…

At #EARD2023, expect more than talks. With LongeVC, discover groundbreaking research, investment opportunities & connect with key players like our @WilliamUsdin. Aging research meets decentralized science here. #Longevity #DeSci tinyurl.com/36s2skaf

Mark those calendars. #ARDD2023 is here, Aug 28 – Sep 1. And Garri Zmudze & Sergey Jakimov from #LongeVC have some riveting news for us! Stay tuned, and shoutout to board members Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs), Dr. Evelyne Yehudit Bischof & Thomas Rando , who'll be there! agingpharma.org